Tuomas Kiviniemi
MD, PhD, FESC
tuoski@utu.fi ORCID identifier: https://orcid.org/0000-0002-0908-3741 |
Cardiology; Clinical trials; Atrial fibrillation; Coronary artery disease; Percutaneous coronary intervention; Wearables; Anticoagulation; Bleeding; Translational research
Professor of cardiology, PI in CAREFIB and LAA-CLOSURE
Tuomas Kiviniemi, MD, PhD, FESC, is Professor of Cardiology at the University of Turku and Chief Physician at the Heart Center, Turku University Hospital. His clinical and academic work focuses on interventional cardiology, atrial fibrillation, and cardiovascular risk in patients undergoing cardiac procedures. He also serves as President of the Finnish Cardiac Society for the 2024–2026 term, contributing nationally to cardiovascular care development and professional education.
Professor Kiviniemi completed his medical and doctoral degrees at the University of Turku and later broadened his research expertise during a research fellowship at Brigham and Women’s Hospital, Harvard Medical School. His research integrates clinical trials, biomarker studies, translational science, and outcome research in percutaneous and surgical cardiac interventions. He leads the multidisciplinary CAREFIB Consortium, which encompasses several major investigator-initiated studies, including CAREBANK, CAREiCON and the LAA-CLOSURE randomized trial program investigating stroke prevention strategies in atrial fibrillation.
His scientific output includes peer-reviewed publications, book chapters, trial leadership roles, and long-term collaborations with computational medicine, imaging, and device-innovation groups.
In addition to his academic duties, Professor Kiviniemi is a frequently invited expert in the European Society of Cardiology community, contributing as an abstract reviewer, session chair, and presenter in acute coronary syndromes and interventional cardiology themes.
At the national level, he has served as a long-standing member and chair within the Finnish Cardiac Society, holding multiple leadership and editorial roles. As President of the Society 2024-2026, he advanced cardiovascular education, guidelines, and professional collaboration across Finland.
Professor Kiviniemi’s current research interests span atrial fibrillation detection technologies, outcomes after cardiac surgery, advanced imaging, and digital health solutions. His work continues to bridge clinical cardiology with engineering, data science, and translational discovery, supporting the University of Turku’s strategic strengths in cardiovascular medicine.
At the University of Turku, Professor Kiviniemi is actively involved in supervising doctoral trainees in cardiology, and he has mentored more than ten completed PhD theses. His teaching activities also include specialist training and contributions to national cardiology textbooks.
- Disadvantages of high fluid infusion rate in cardiac surgery (2022)
- European Journal of Anaesthesiology
(B1 Non-refereed article in a scientific journal) - EKG-tapaus (2022)
- Sydänääni: Suomen Kardiologisen Seuran Lehti
(Other publication) - End-to-end sensor fusion and classification of atrial fibrillation using deep neural networks and smartphone mechanocardiography (2022)
- Physiological Measurement
(A1 Refereed original research article in a scientific journal) - Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation - the FinCV-4 study (2022)
- Annals of Medicine
(A1 Refereed original research article in a scientific journal) - Late incidence and recurrence of new-onset atrial fibrillation after isolated surgical aortic valve replacement (2022)
- Journal of Thoracic and Cardiovascular Surgery
(A1 Refereed original research article in a scientific journal) - Mechanocardiography-Based Measurement System Indicating Changes in Heart Failure Patients during Hospital Admission and Discharge (2022)
- Sensors
(A1 Refereed original research article in a scientific journal) - Mechanocardiography in the Detection of Acute ST Elevation Myocardial Infarction: The MECHANO-STEMI Study (2022)
- Sensors
(A1 Refereed original research article in a scientific journal) - Polygenic Risk Scores for Predicting Adverse Outcomes After Coronary Revascularization (2022)
- American Journal of Cardiology
(A1 Refereed original research article in a scientific journal) - Advanced interatrial block predicts ineffective cardioversion of atrial fibrillation: a FinCV2 cohort study (2021)
- Annals of Medicine
(A1 Refereed original research article in a scientific journal) - Anticoagulation Therapy After Biologic Aortic Valve Replacement (2021)
- Frontiers in Cardiovascular Medicine
(A1 Refereed original research article in a scientific journal)
- CAREiCON01.09.2024 - 31.08.2027
- Internal Medicine
- LAA-CLOSURE01.09.2024 - 31.08.2028
- Internal Medicine
- MIRACLE01.10.2023 - 30.09.2027
- Internal Medicine
- CAREBANK STS01.01.2023 - 31.12.2028
- Internal Medicine
- CAREBANK01.01.2021 - 31.12.2025
- Internal Medicine
- KLL Moore4Medical01.06.2020 - 30.09.2023
- Internal Medicine



